Similar to rheumatoid arthritis (RA), several trials in PsA have shown excellent clinical results with anti-TNFα agents such as etanercept [6, 7], infliximab [8], and adalimumab [9, 10]. The gene discussed is TNF; the disease is rheumatoid arthritis.